Lee Greenberger, PhD, The Leukemia & Lymphoma Society, Rye Brook, NY
Recorded on December 22, 2021
Each year, blood cancer professionals gather at the American Society of Hematology Annual Meeting to discuss the latest updates in blood cancer research, treatment, and clinical trials. In this episode, Lee Greenberger, PhD, Chief Scientific Officer and Senior Vice President at The Leukemia & Lymphoma Society, highlights the inflection points from the 63rd ASH Annual Meeting, including CAR T-cell therapy, bi-specific antibodies, and cell-free DNA. He reviews the latest data on Covid-19 and effectiveness of vaccinations in the blood cancer patient population. Tune in to this informative update today!